Peter E. Boyd - 15 Oct 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
15 Oct 2025
Net transactions value
-$70,000
Form type
4
Filing time
17 Oct 2025, 14:00:39 UTC
Previous filing
29 Sep 2025
Next filing
05 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boyd Peter E. SVP IT, HR, & Communications C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 16 Oct 2025 0001739816

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Sale $70,000 -10,000 -3.6% $7.00 268,323 15 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Remarks:

SVP IT, HR, & Communications